netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

Hameatology/Oncology related Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Haematology/Oncology related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter.

 

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (0,2)
Drugs for cytotoxic-induced side-effects (3,2)
08.01.01 Alkylating drugs (10,4)
08.01.02 Anthracyclines and other cytotoxic antibiotics (10,0)
08.01.03 Antimetabolites (12,2)
08.01.04 Vinca alkaloids and etoposide (7,0)
08.01.05 Other antineoplastic drugs (29,5)
Amsacrine (1,0)
Arsenic trioxide (1,0)
Bortezomib (1,0)
Brentuximab vedotin (1,0)
Cetuximab (1,0)
Dacarbazine and Temozolomide (2,0)
Erlotinib (1,0)
Hydroxycarbamide (1,0)
Ipilimumab (1,0)
Pentostatin (1,0)
Platinum compounds (3,1)
Procarbazine (1,0)
Protein kinase inhibitors (16,0)
Taxanes (4,0)
Topoisomerase I inhibitors (3,0)
Trabectedin (1,0)
Trastuzumab (3,0)
Tretinoin (1,0)
Vismodegib (0,1)
08.02 Drugs affecting the immune response (1,0)
08.02.01 Antiproliferative immunosuppressants (2,1)
08.02.02 Corticosteroids and other immunosuppressants (5,3)
08.02.03 Anti-lymphocyte monoclonal antibodies (5,0)
08.02.04 Other immunomodulating drugs (13,1)
Interferon Alfa (2,1)
Interferon beta (4,0)
Glatiramer acetate (1,0)
Lenalidomide, pomalidomide, and thalidomide (1,0)
Mifamurtide (1,0)
Natalizumab (1,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (1,1)
08.03.02 Progestogens (3,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (6,2)
08.03.04.02 Prostate cancer and gonadorelin analogues (1,1)
Gonadorelin analogues (1,0)
Anti-androgens (8,1)
08.03.04.03 Somatostatin analogues (4,0)
netFormulary